Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The Ocular Surface|April 10, 2012
Appraisal of patient-reported outcome instruments available for randomized clinical trials in dry eye: revisiting the standardsIsabelle Guillemin, Carolyn Begley, Robin Chalmers, et al.
European Journal of Biochemistry|June 26, 2003
Sequences and structural organization of phospholipase A2 genes from Vipera aspis aspis, V. aspis zinnikeri and Vipera berus berus venom. Identification of the origin of a new viper population based on ammodytin I1 heterogeneityIsabelle Guillemin, Christiane Bouchier, Thomas Garrigues, et al.
Health and Quality of Life Outcomes|December 19, 2008
Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trialMuriel Viala-Danten, Susan Martin, Isabelle Guillemin, et al.
Toxicon : Official Journal of the International Society on Toxinology|October 2, 2007
Phospholipase A2 diversity and polymorphism in European viper venoms: paradoxical molecular evolution in ViperinaeVirginie M Jan, Isabelle Guillemin, Annie Robbe-Vincent, et al.
Journal of Cancer Survivorship : Research and Practice|December 14, 2022
Development of a disease conceptual model of patient experience with metastatic colorectal cancer: identification of the most salient symptoms and impactsIsabelle Guillemin, Mahesh Darpelly, Brendon Wong, et al.
Proteomics|December 17, 2004
A subcellular prefractionation protocol for minute amounts of mammalian cell cultures and tissueIsabelle Guillemin, Michael Becker, Kornelia Ociepka, et al.
BMC Health Services Research|August 9, 2007
Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ) in glaucoma using a qualitative studyJean-Philippe Nordmann, Philippe Denis, Marc Vigneux, et al.
Microbiology (Reading, England)|October 12, 1999
Purification and inhibition by quinolones of DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinumIsabelle Guillemin, Wladimir Sougakoff, Emmanuelle Cambau, et al.
The Patient|March 8, 2018
Living with Merkel Cell Carcinoma (MCC): Development of a Conceptual Model of MCC Based on Patient ExperiencesHoward L Kaufman, Carla Dias Barbosa, Isabelle Guillemin, et al.
Orphanet Journal of Rare Diseases|June 20, 2018
How to address the challenges of evaluating treatment benefits-risks in rare diseases? A convergent mixed methods approach applied within a Merkel cell carcinoma phase 2 clinical trialMurtuza Bharmal, Isabelle Guillemin, Alexia Marrel, et al.
Pageof 5